NEWSROOM

NASDAQ

Lipella Pharmaceuticals Reports Positive Topline Phase 2a Results for LP-310 in the Treatment of Oral Lichen Planus

Lipella Pharmaceuticals Reports Positive Topline Phase 2a Results for LP-310 in the Treatment of Oral Lichen Planus

Feb 11, 2025

LP-310 Treatment Demonstrates Clinically Meaningful Reductions in Pain, Ulceration, and Inflammation Across All Key Metrics Findings Highlight Favorable Safety Profile and Tolerability of Twice-Daily Oral Rinse Multicenter Phase 2a Trial Advancing to Higher Treatment Dose with Recruitment Expected to Conclude the First Half of 2025 Lipella Leadership to Present Findings at BIO CEO & Investor Conference on Tuesday, February 11, 2025, at 2:30 p.m. EST PITTSBURGH, Feb. 11, 2025 - PRISM...

Oncocyte Prices $29.1 Million Equity Offering

Oncocyte Prices $29.1 Million Equity Offering

Feb 10, 2025

Proceeds Expected to Fund Transplant Assay Through FDA IVD Clearance and Commercial Launch Strategic Partner Bio-Rad Invests, Boosts Support for Trial and Commercialization IRVINE, Calif., Feb. 10, 2025 - PRISM MediaWire - Oncocyte Corp. (Nasdaq: OCX), a pioneering diagnostics technology company, today announced that it has entered into securities purchase agreements with existing investors for a registered direct offering (“Registered Direct Offering”) and concurrent private placement (“PIPE...

Auddia Announces Continued Favorable 30-day Retention and the Launch of Commercial Subscriptions

Auddia Announces Continued Favorable 30-day Retention and the Launch of Commercial Subscriptions

Feb 10, 2025

faidr 30-day retention continues to build Upgraded subscription conversion optimization platform launched last week Subscription revenue guidance to be reported end of Q1 BOULDER, CO, February 10, 2024 - PRISM MediaWire - Auddia Inc. (NASDAQ: AUUD) (NASDAQ: AUUDW) (“Auddia” or the “Company”), a technology company that has built a proprietary AI platform for audio identification and classification to reinvent how consumers engage with audio, today announced that 30-day user retention metrics...

AmpliTech Group’s 5G Division Receives Initial Order For Three Configurations Of The Company’s Suite of 5G ORAN Radios

AmpliTech Group’s 5G Division Receives Initial Order For Three Configurations Of The Company’s Suite of 5G ORAN Radios

Feb 6, 2025

Hauppauge, NY, February 6, 2025 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced the receipt of a purchase order by its 5G Division to provide three different 5G ORAN Radio...

Aclarion Announces Northwestern Medicine as First CLARITY Trial Site

Aclarion Announces Northwestern Medicine as First CLARITY Trial Site

Feb 6, 2025

Northwestern Medicine is a global leader in clinical trial research, including spine CLARITY is a randomized study designed to demonstrate Nociscan’s ability to improve surgical outcomes while reducing costs for chronic low back pain Nociscan aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI) BROOMFIELD, Colo., Feb. 6, 2025 - PRISM MediaWire - Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW),...

Lipella Pharmaceuticals Reports Positive Topline Phase 2a Results for LP-310 in the Treatment of Oral Lichen Planus

Lipella Pharmaceuticals Granted FDA Approval for Expanded Access Program for LP-310 in Oral Lichen Planus

Feb 6, 2025

PITTSBURGH, February 6, 2025 - PRISM MediaWire - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on developing innovative therapies for unmet medical needs, today announced that the U.S. Food and Drug Administration (FDA) has granted approval for an Expanded Access Program (EAP) for LP-310, an oral rinse formulation designed to treat oral lichen planus (OLP). LP-310 is an innovative, localized therapy formulated to...

AmpliTech Group’s 5G Division Receives Initial Order For Three Configurations Of The Company’s Suite of 5G ORAN Radios

AmpliTech Group’s AmpliTech Inc. Division Secures Additional Purchase Orders Under 5-Year Basic Order Agreement With Fortune 1000 U.S. Company

Feb 4, 2025

PO’s received by the company during Q1 2025 already exceed US$1 Million, all deliverable within Fiscal Year 2025 Hauppauge, NY, February 4, 2025 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly,...

SKYX to Present at LD Micro Summit Today February 4, 2025

SKYX to Present at LD Micro Summit Today February 4, 2025

Feb 4, 2025

MIAMI, February 4, 2025 - PRISM MediaWire - SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive smart platform technology company with over 97 issued and pending patents in the U.S. and globally, and over 60 lighting and home décor websites with a mission to make homes and buildings become smart, safe, and advanced as the new standard will participate in the inaugural LD Micro Summit, taking place on February 4, 2025, at the Lago Mar Beach Resort & Club in...

Aclarion Announces Northwestern Medicine as First CLARITY Trial Site

Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded

Feb 4, 2025

The Company has secured nearly $20 million in gross proceeds in 2025 ensuring complete funding for its pivotal CLARITY trial CLARITY is a prospective, randomized, multicenter study to validate Nociscan’s ability to improve surgical outcomes Nociscan aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI) Broomfield, CO, February 4, 2025 - PRISM MediaWire - Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON,...

Aclarion to Showcase Groundbreaking NOCISCAN Technology at the Selby Spine Conference

Aclarion to Showcase Groundbreaking NOCISCAN Technology at the Selby Spine Conference

Jan 31, 2025

Dr. Sigurd Berven to Highlight NOCISCAN Capabilities, Combining MR Spectroscopy and Augmented Intelligence (AI) NOCISCAN as New Gold Standard in Identifying a Source of Discogenic Pain BROOMFIELD, Colo., January 31, 2025 - PRISM MediaWire - Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain,...

AmpliTech Group’s 5G Division Receives Initial Order For Three Configurations Of The Company’s Suite of 5G ORAN Radios

AmpliTech Group To Feature Latest ORAN 5G High Speed Products At The MWC Show in Barcelona

Jan 31, 2025

Also Participating At INDUSTRY DAY 25: TOWARD OPEN 6G NETWORKS - An Annual Forum to Connect Industry, Government, and Academia Being Held at Northeastern University In Boston, Massachusetts Hauppauge, NY, January 31, 2025 – PRISM MediaWire - AmpliTech Group, Inc (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G, and other communications networks, including the design of complete 5G/6G systems, and a global...

AmpliTech Group’s 5G Division Receives Initial Order For Three Configurations Of The Company’s Suite of 5G ORAN Radios

AmpliTech Group Announces Receipt of Formal Patent From United States Patent and Trademark Office For Its Optimized 5G Front End Technology

Jan 30, 2025

Hauppauge, NY, January 30, 2025 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today is pleased to announce that it has officially received a patent number from the United States Patent and...

Blackboxstocks, Inc. Appoints Grant Evans to the Company’s Board of Directors

Blackboxstocks, Inc. Appoints Grant Evans to the Company’s Board of Directors

Jan 27, 2025

Dallas, January 27, 2025 - PRISM MediaWire - Blackboxstocks Inc. (NASDAQ: BLBX) (“Blackbox” or the “Company”), a financial technology and social media hybrid platform offering real-time proprietary analytics for stock and options traders, announced today that on January 21, 2025 the Company appointed Grant Evans as a Director to replace Ray Balestri who passed away unexpectedly earlier this month. Mr. Evans has been a partner with Pacific Coast Partners, an advisory firm focusing on mergers...

Blackboxstocks, Inc. Appoints Grant Evans to the Company’s Board of Directors

Blackboxstocks, Inc. Secures Financing of up to $2,000,000 in Anticipation of Potential Merger

Jan 22, 2025

Debentures are convertible into common stock priced at 175% premium to market from the prior days’ closing price with a $5.00 floor Dallas, January 22, 2025 - PRISM MediaWire - Blackboxstocks Inc. (NASDAQ: BLBX), (“Blackbox” or the “Company”), a financial technology and social media hybrid platform offering real-time proprietary analytics for stock and options traders, announced today that on January 17, 2025 the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) ...

AmpliTech Group Announces Appointment Of Shailesh “Sonny” Modi To Its Board Of Directors

AmpliTech Group Announces Appointment Of Shailesh “Sonny” Modi To Its Board Of Directors

Jan 21, 2025

Hauppauge, NY, January 21, 2025 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW, “AmpliTech”), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today is pleased to announce the appointment of Mr. Shailesh “Sonny” Modi to its Board of...

Blackboxstocks, Inc. Appoints Grant Evans to the Company’s Board of Directors

Blackboxstocks, Inc. and Evtec Aluminium Limited Mutually Agree to Terminate Share Exchange Agreement

Jan 17, 2025

Blackbox is actively pursuing other strategic merger options to enhance stockholder value DALLAS, Jan. 17, 2025 - PRISM MediaWire - Blackboxstocks Inc. (NASDAQ: BLBX), (“Blackbox” or the “Company”), a financial technology and social media hybrid platform offering real-time proprietary analytics for stock and options traders, announced today that on January 13, 2025 the Company and Evtec Aluminium Limited (“Evtec”) mutually agreed to terminate the Share Exchange Agreement executed on December...

SKYX to Present at LD Micro Summit Today February 4, 2025

SKYX Announces that it Will Begin Supplying its Products to 140 Commercial Units in January 2025

Jan 15, 2025

As SKYX Continues to Grow its Market Penetration, it is Expected to Supply Developer Jeremiah Baron Companies Products to a Total of 1000 Mixed-Use Residential and Commercial Units The Products that are Expected to be Supplied to the Mixed-Use Project will include Ceiling Outlet Receptacles, Smart Plug & Play Platform Products including Lighting, Ceiling Fans, Recessed Lights, EXIT Signs, Emergency Lights, Down Lights, and Indoor and Outdoor Wall Lights MIAMI, FL, January 15, 2025 -...

LuxUrban Issues Corporate update and 2025 Revenue Guidance of $62–$67 million

LuxUrban Issues Corporate update and 2025 Revenue Guidance of $62–$67 million

Jan 15, 2025

Streamlined Operations and NYC Focus Set the Stage for 2025 Growth RevPAR Gains and Optimized Portfolio Highlight Operational Momentum MIAMI, Jan. 15, 2025 - PRISM MediaWire - LuxUrban Hotels Inc. (Nasdaq: LUXH), a hospitality company that leases entire hotels on a long-term basis, manages these hotels, and rents out rooms to guests in the properties it leases, today provided a comprehensive corporate update, highlighting recent business achievements and sharing its 2025 revenue guidance and...

BranchOut Food Projects $9 Million in H1 2025 Revenue, Highlighted by $4 Million from Nation’s Largest Warehouse Club

BranchOut Food Projects $9 Million in H1 2025 Revenue, Highlighted by $4 Million from Nation’s Largest Warehouse Club

Jan 15, 2025

Breakthrough Multi-Product, Multi-Region Expansion: Nation’s Largest Warehouse Club Expands Multiple Products Across Four Regions for Transformational Growth Key Highlights: H1 Revenue Surge: Projecting $9M in total revenue, up 218% from the prior year, with strong momentum expected throughout 2025. Nation’s Largest Warehouse Club: Expands BranchOut’s product count and regional footprint across four major markets, driving $4M in H1 sales. Peru Facility Fully Operational: BranchOut celebrates...

LuxUrban Issues Corporate update and 2025 Revenue Guidance of $62–$67 million

Lux Urban Hotels Embraces the Future with Digital Currency–Powered Guest Experiences

Jan 14, 2025

Guests staying at Lux Urban Hotels will soon have the option to pay for their stays using a variety of blockchain-based digital currencies, offering a seamless and decentralized payment experience MIAMI, Jan. 14, 2025 - PRISM MediaWire - LuxUrban Hotels Inc. (Nasdaq: LUXH) a premier name in contemporary urban hospitality, is proud to announce an innovative partnership to enable digital currency payments to all nine properties in the Company’s portfolio. By integrating blockchain-based payment...

Sono-Tek Reports Third Quarter and Nine Months Fiscal 2025 Financial Results

Sono-Tek Reports Third Quarter and Nine Months Fiscal 2025 Financial Results

Jan 13, 2025

Reports Third Consecutive Quarter of Revenue above $5 million First Nine Months Revenue Growth of 3% YOY Backlog Remains Strong at $10.6 Million Provides Guidance for Revenue of over $20 million and Continued Profitability for Fiscal Year 2025 MILTON, N.Y., January 13, 2025 - PRISM MediaWire - Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today reported financial results for the third quarter and nine months of fiscal year 2025,...

Quantum Computing Era is Here and Growing: The Dawn of Practical Artificial Intelligence (AI) and Cybersecurity Applications

Quantum Computing Era is Here and Growing: The Dawn of Practical Artificial Intelligence (AI) and Cybersecurity Applications

Jan 8, 2025

Hauppauge, NY, January 8, 2025 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today issued a technical and business opinion written by the company’s CEO/CTO Mr. Fawad Maqbool, which is...

Klotho Neurosciences to Present at Biotech Showcase 2025 during J.P. Morgan Healthcare Week in San Francisco

Klotho Neurosciences to Present at Biotech Showcase 2025 during J.P. Morgan Healthcare Week in San Francisco

Jan 8, 2025

Company to present at 3:00 p.m. PT on Tuesday, January 14, at the Hilton San Francisco Union Square New York, NY, January 8, 2025 - PRISM MediaWire - Klotho Neurosciences, Inc. (NASDAQ: KLTO), a specialty biotechnology company focused on developing cell and gene therapies for amyotrophic lateral sclerosis (ALS), Alzheimer’s, and Parkinson’s disease, announces that it will present at Biotech Showcase 2025, an event expected to include over 3,200 healthcare professionals with more than 1,200...

Oncocyte Prices $29.1 Million Equity Offering

Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer

Jan 8, 2025

Dr. Billings is a renowned diagnostics specialist with a history of commercializing novel assays in precision medicine Will provide key regulatory and reimbursement support Will assist business development efforts and strategic partnerships Irvine, Calif., Jan. 8, 2025 - PRISM MediaWire - Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, announces the appointment of Dr. Paul Billings as the company’s Consulting Chief Medical Officer. In this part-time role, he will support a...

PRISM MarketView Spotlights Quoin Pharmaceuticals CEO Dr. Michael Myers as Specialty Pharma Shares News of Highly Positive Interim Data in Most Advanced, Comprehensive Netherton Syndrome Trials

PRISM MarketView Spotlights Quoin Pharmaceuticals CEO Dr. Michael Myers as Specialty Pharma Shares News of Highly Positive Interim Data in Most Advanced, Comprehensive Netherton Syndrome Trials

Jan 7, 2025

Published Before-and-After Photos Highlight Dramatic Improvements in Netherton Syndrome Patient Treated with QRX003 New York, January 07, 2024 -PRISM MediaWire - PRISM MarketView has released an exclusive interview with Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) CEO Dr. Michael Myers, who shares the company’s notable interim data in its ongoing Netherton Syndrome clinical trials. Quoin, a clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, is addressing unmet...

EzFill Holdings, Inc. Successfully Closes Acquisition of Shell Fleet, Accelerating Nationwide Mobile Fueling Expansion

EzFill Holdings, Inc. Successfully Closes Acquisition of Shell Fleet, Accelerating Nationwide Mobile Fueling Expansion

Jan 7, 2025

Following the Closing of its 2024 Transactions, EzFill is Now Operating in Miami, West Palm Beach, Orlando, Tampa, Jacksonville, Los Angeles, San Francisco, Nashville, Detroit, Dallas, Houston, Austin, San Antonio, and Phoenix MIAMI, January 07, 2025 – EzFill Holdings, Inc. (NASDAQ: EZFL), a leading mobile fueling company, today announced the completion of its purchase of a fleet of trucks from Shell Retail and Convenience Operations LLC (“Shell”), a wholly owned subsidiary of Shell Oil...

Oncocyte Prices $29.1 Million Equity Offering

Oncocyte Expands Market Opportunity for VitaGraft™ Kidney

Jan 6, 2025

Medicare coverage expanded following study showing that monitoring with Oncocyte’s assay significantly reduces time to rejection diagnosis in patients with newly developed donor-specific antibodies (DSA) MolDX confirms eligibility for billing under current Local Coverage Determination (LCD) and Z-Code Up to 20% of patients will have detectable DSA within the first five years post kidney transplant, representing greater than 10,000 patients per year in the US.1 From time of onset of dnDSA, 24%...

Quantum Computing Era is Here and Growing: The Dawn of Practical Artificial Intelligence (AI) and Cybersecurity Applications

AmpliTech Group Announces Receipt of Notice of Allowance for Another Patent For Its LNA Technology

Jan 6, 2025

Hauppauge, NY, January 6, 2025 – PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today is pleased to announce that the United States Patent and Trademark Office (USPTO) has issued another Notice...

AmpliTech Group Releases Letter To Shareholders

AmpliTech Group Releases Letter To Shareholders

Dec 31, 2024

Hauppauge, NY, December 31, 2024 – PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced the release of a Letter to Shareholders from its CEO/CTO Mr. Fawad Maqbool. Dear Shareholders...

AmpliTech Group Releases Letter To Shareholders

AmpliTech Group Announces Pricing of $10.0 Million Registered Direct Offering

Dec 30, 2024

HAUPPAUGE, N.Y., Dec. 30, 2024 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW) (the “Company”), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced that it has entered into one or more securities purchase agreements with certain...